Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
AIDS (London, England)|July 11, 2017
Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapyCatherine A Chappell, Mohammed Lamorde, Shadia Nakalema, et al.
Plos One|March 28, 2020
Impact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and bloodLisa B Haddad, Alison Swaims-Kohlmeier, C Christina Mehta, et al.
JCI Insight|July 21, 2022
Spatiotemporal regulation of human IFN-ε and innate immunity in the female reproductive tractNollaig M Bourke, Sharon L Achilles, Stephanie U-Shane Huang, et al.
Contraception|October 18, 2022
Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trialsMelissa J Chen, Jeffrey T Jensen, Andrew M Kaunitz, et al.
Contraception|August 3, 2022
Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trialsJeffrey T Jensen, Andrew M Kaunitz, Sharon L Achilles, et al.
Contraception|August 3, 2022
Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy womenAndrew M Kaunitz, Sharon L Achilles, János Zatik, et al.
International Journal of Systematic and Evolutionary Microbiology|October 3, 2023
Amygdalobacter indicium gen. nov., sp. nov., and Amygdalobacter nucleatus sp. nov., gen. nov.: novel bacteria from the family Oscillospiraceae isolated from the female genital tractSujatha Srinivasan, Michele N Austin, Tina L Fiedler, et al.
Plos One|June 5, 2024
Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal ringsSharon L Achilles, Clifton W Kelly, Craig J Hoesley, et al.
AIDS Research and Human Retroviruses|January 15, 2019
The Evolving Facets of Bacterial Vaginosis: Implications for HIV TransmissionLyle R McKinnon, Sharon L Achilles, Catriona S Bradshaw, et al.
AIDS Research and Human Retroviruses|August 13, 2021
A Randomized, Open-Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study)Ian M McGowan, Sylvain Chawki, Craig W Hendrix, et al.
Pageof 5